GxP AI Compliance: Guardrails for Inspection Readiness
Learn frameworks for GxP-safe AI. Covers RAG, audit trails, and data isolation to ensure 21 CFR Part 11 and Annex 11 compliance in pharma.
Back to Articles
Articles tagged with “annex-11”
Electronic Batch Records in Biotech: GxP & Software Guide
Explore GxP requirements for Electronic Batch Records (EBR) in biotech. Covers FDA 21 CFR Part 11 compliance, validation, and current software options.
Veeva Vault Alternatives: An eQMS & GxP Feature Matrix
Explore Veeva Vault alternatives like MasterControl & TrackWise. Our 2026-updated feature matrix for life sciences eQMS analyzes GxP readiness, AI capabilities, FDA QMSR compliance, and 21 CFR Part 11.
55 min read
11/11/2025
DocuSign in Pharma: A Guide to 21 CFR Part 11 Compliance
An analysis of how Docusign (formerly DocuSign) is used for electronic signatures in pharma and life sciences. Learn how it can meet FDA 21 CFR Part 11 compliance with its Life Sciences modules and IAM platform, updated for 2026.
21 CFR Part 11: IT Guide to Electronic Records & Signatures
Updated 2026 guide for IT on 21 CFR Part 11. Covers FDA CSA guidance, AI compliance, electronic records & signatures, system validation, audit trails & data integrity
Navigating Regulatory Compliance in RTSM Systems for Clinical Trials
A comprehensive guide to regulatory requirements and best practices for implementing compliant Randomization and Trial Supply Management (RTSM) systems in clinical trials, covering FDA, EMA, and global standards.